What I do at MMV:
My role is to support product launches and uptake of new medicines for malaria, particularly tafenoquine, with a primary geographical focus on malaria-endemic countries in Asia and Latin America.
Why I work at MMV:
Coming from a public health background, I am very interested in following-up on the development of new antimalarial medicines, with a patient-focused and not- for-profit perspective. I have great respect for organizations that are dedicated to developing treatments for neglected diseases and my personal ambitions are strongly aligned with MMV’s aim to tackle the challenges associated with access to new and effective antimalarials in resource-limited settings. I believe that with its global partner network, and integrated approach (combining clinical, pharmaceutical and access analysis), MMV’s potential to have a broad impact by discovering, developing and facilitating access to critical life-saving medicine is unparalleled. I am honoured to be a part of this professional, dynamic and dedicated team.
More about me:
I hold a Doctor of Pharmacy and various diplomas in Public Health, Hospital Pharmacy, Hospital Hygiene and Pharmaco-Epidemiology. Working with Médecins Sans Frontières (MSF) for 12 years, I gained extensive knowledge and experience with access issues related to medicines. I worked with MSF’s Campaign for Access to Essential Medicines, mainly in Middle Income Countries (China and India) on access issues related to price, intellectual property restrictions, regulatory hurdles, importation requirements and quality.Earlier on in my career, I worked with the Centers for Disease Control and Prevention (CDC) on immunization, and with the World Health Organization (WHO) supporting National Medicines Regulatory Authorities. I have also worked as a hospital pharmacist in France and in a small public manufacturing and hospital control unit.
Ask me about:
MSF, access and quality issues, as well as mountaineering, cycling or swimming.